CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder [Phase 2]
Summary
Phase 2 safety and efficacy study of ELND005 as an adjunctive maintenance treatment in Bipolar I Disorder was terminated; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OPKO Health, Inc. | Conditions: Bipolar 1 Disorder | Phase 2 | Status: TERMINATED | Results posted: 2015-10-12